APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Preparation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Transdermal Preparation Market Outlook and Growth Opportunities 2026

22 December 2025202 pages

Choose your research edition.

Industry ResearchTransdermal Preparation Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Preparation Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Transdermal Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Preparation Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Preparation Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Transdermal Preparation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Transdermal Preparation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Transdermal Preparation market include Novastage Pharmaceuticals (Shenzhen), Novartis, Luye Pharma Group, Hunan Jiudian Pharmaceutical, Harbin Hexinotai Pharmaceutical Technology, GSK, Demo Technology, Guangzhou Continent Biomedical Technology and Beijing Tide Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Preparation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Preparation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Preparation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Preparation market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Preparation Segment by Company

Novastage Pharmaceuticals (Shenzhen)

Novartis

Luye Pharma Group

Hunan Jiudian Pharmaceutical

Harbin Hexinotai Pharmaceutical Technology

GSK

Demo Technology

Guangzhou Continent Biomedical Technology

Beijing Tide Pharmaceutical

Viatris

Transdermal Corporation

Nitto

MEDRx

Medpharm

ERCO Pharma

4P Therapeutics

Transdermal Preparation Segment by Type

Injectable Preparations

Non Injectable Preparations

Transdermal Preparation Segment by Application

Hospital

Clinic

Other

Transdermal Preparation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transdermal Preparation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transdermal Preparation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transdermal Preparation significant trends, drivers, influence factors in global and regions.

6. To analyze Transdermal Preparation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Preparation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Preparation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Preparation industry.

Chapter 3: Detailed analysis of Transdermal Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transdermal Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transdermal Preparation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transdermal Preparation Industry Trends Table 2. Transdermal Preparation Industry Drivers Table 3. Transdermal Preparation Industry Opportunities and Challenges Table 4. Transdermal Preparation Industry Restraints Table 5. Global Transdermal Preparation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transdermal Preparation Revenue Share by Company (2021-2026) Table 7. Global Transdermal Preparation Sales Volume by Company (k units) & (2021-2026) Table 8. Global Transdermal Preparation Sales Volume Share by Company (2021-2026) Table 9. Global Transdermal Preparation Average Price (US$/unit) of Company (2021-2026) Table 10. Global Transdermal Preparation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transdermal Preparation Key Company Manufacturing Base & Headquarters Table 12. Global Transdermal Preparation Company, Product Type & Application Table 13. Global Transdermal Preparation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injectable Preparations Table 18. Significant Companies of Non Injectable Preparations Table 19. Global Transdermal Preparation Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Transdermal Preparation Sales Volume by Type (2021-2026) & (k units) Table 21. Global Transdermal Preparation Sales Volume by Type (2027-2032) & (k units) Table 22. Global Transdermal Preparation Sales Volume Share by Type (2021-2026) Table 23. Global Transdermal Preparation Sales Volume Share by Type (2027-2032) Table 24. Global Transdermal Preparation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Transdermal Preparation Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Transdermal Preparation Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Transdermal Preparation Sales Value Share by Type (2021-2026) Table 28. Global Transdermal Preparation Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Transdermal Preparation Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Transdermal Preparation Sales Volume by Application (2021-2026) & (k units) Table 34. Global Transdermal Preparation Sales Volume by Application (2027-2032) & (k units) Table 35. Global Transdermal Preparation Sales Volume Share by Application (2021-2026) Table 36. Global Transdermal Preparation Sales Volume Share by Application (2027-2032) Table 37. Global Transdermal Preparation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Transdermal Preparation Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Transdermal Preparation Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Transdermal Preparation Sales Value Share by Application (2021-2026) Table 41. Global Transdermal Preparation Sales Value Share by Application (2027-2032) Table 42. Global Transdermal Preparation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Transdermal Preparation Sales by Region (2021-2026) & (k units) Table 44. Global Transdermal Preparation Sales Market Share by Region (2021-2026) Table 45. Global Transdermal Preparation Sales by Region (2027-2032) & (k units) Table 46. Global Transdermal Preparation Sales Market Share by Region (2027-2032) Table 47. Global Transdermal Preparation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Transdermal Preparation Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Transdermal Preparation Sales Value Share by Region (2021-2026) Table 50. Global Transdermal Preparation Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Transdermal Preparation Sales Value Share by Region (2027-2032) Table 52. Global Transdermal Preparation Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Transdermal Preparation Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Transdermal Preparation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Transdermal Preparation Sales by Country (2021-2026) & (k units) Table 57. Global Transdermal Preparation Sales Market Share by Country (2021-2026) Table 58. Global Transdermal Preparation Sales by Country (2027-2032) & (k units) Table 59. Global Transdermal Preparation Sales Market Share by Country (2027-2032) Table 60. Global Transdermal Preparation Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Transdermal Preparation Sales Value Market Share by Country (2021-2026) Table 62. Global Transdermal Preparation Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Transdermal Preparation Sales Value Market Share by Country (2027-2032) Table 64. Novastage Pharmaceuticals (Shenzhen) Company Information Table 65. Novastage Pharmaceuticals (Shenzhen) Business Overview Table 66. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio Table 68. Novastage Pharmaceuticals (Shenzhen) Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Transdermal Preparation Product Portfolio Table 73. Novartis Recent Development Table 74. Luye Pharma Group Company Information Table 75. Luye Pharma Group Business Overview Table 76. Luye Pharma Group Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Luye Pharma Group Transdermal Preparation Product Portfolio Table 78. Luye Pharma Group Recent Development Table 79. Hunan Jiudian Pharmaceutical Company Information Table 80. Hunan Jiudian Pharmaceutical Business Overview Table 81. Hunan Jiudian Pharmaceutical Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio Table 83. Hunan Jiudian Pharmaceutical Recent Development Table 84. Harbin Hexinotai Pharmaceutical Technology Company Information Table 85. Harbin Hexinotai Pharmaceutical Technology Business Overview Table 86. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio Table 88. Harbin Hexinotai Pharmaceutical Technology Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GSK Transdermal Preparation Product Portfolio Table 93. GSK Recent Development Table 94. Demo Technology Company Information Table 95. Demo Technology Business Overview Table 96. Demo Technology Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Demo Technology Transdermal Preparation Product Portfolio Table 98. Demo Technology Recent Development Table 99. Guangzhou Continent Biomedical Technology Company Information Table 100. Guangzhou Continent Biomedical Technology Business Overview Table 101. Guangzhou Continent Biomedical Technology Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio Table 103. Guangzhou Continent Biomedical Technology Recent Development Table 104. Beijing Tide Pharmaceutical Company Information Table 105. Beijing Tide Pharmaceutical Business Overview Table 106. Beijing Tide Pharmaceutical Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio Table 108. Beijing Tide Pharmaceutical Recent Development Table 109. Viatris Company Information Table 110. Viatris Business Overview Table 111. Viatris Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Viatris Transdermal Preparation Product Portfolio Table 113. Viatris Recent Development Table 114. Transdermal Corporation Company Information Table 115. Transdermal Corporation Business Overview Table 116. Transdermal Corporation Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Transdermal Corporation Transdermal Preparation Product Portfolio Table 118. Transdermal Corporation Recent Development Table 119. Nitto Company Information Table 120. Nitto Business Overview Table 121. Nitto Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Nitto Transdermal Preparation Product Portfolio Table 123. Nitto Recent Development Table 124. MEDRx Company Information Table 125. MEDRx Business Overview Table 126. MEDRx Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. MEDRx Transdermal Preparation Product Portfolio Table 128. MEDRx Recent Development Table 129. Medpharm Company Information Table 130. Medpharm Business Overview Table 131. Medpharm Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Medpharm Transdermal Preparation Product Portfolio Table 133. Medpharm Recent Development Table 134. ERCO Pharma Company Information Table 135. ERCO Pharma Business Overview Table 136. ERCO Pharma Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. ERCO Pharma Transdermal Preparation Product Portfolio Table 138. ERCO Pharma Recent Development Table 139. 4P Therapeutics Company Information Table 140. 4P Therapeutics Business Overview Table 141. 4P Therapeutics Transdermal Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. 4P Therapeutics Transdermal Preparation Product Portfolio Table 143. 4P Therapeutics Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Transdermal Preparation Distributors List Table 147. Transdermal Preparation Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Transdermal Preparation Product Image Figure 2. Global Transdermal Preparation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transdermal Preparation Sales (2021-2032) & (k units) Figure 5. Global Transdermal Preparation Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Transdermal Preparation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injectable Preparations Image Figure 10. Non Injectable Preparations Image Figure 11. Global Transdermal Preparation Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Transdermal Preparation Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Transdermal Preparation Sales Volume Share by Type (2021-2032) Figure 14. Global Transdermal Preparation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Transdermal Preparation Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Transdermal Preparation Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Transdermal Preparation Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Transdermal Preparation Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Transdermal Preparation Sales Volume Share by Application (2021-2032) Figure 23. Global Transdermal Preparation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Transdermal Preparation Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Transdermal Preparation Sales Value Share by Application (2021-2032) Figure 26. Global Transdermal Preparation Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Transdermal Preparation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Transdermal Preparation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Transdermal Preparation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 31. North America Transdermal Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Transdermal Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Transdermal Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 37. South America Transdermal Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Transdermal Preparation Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Transdermal Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Transdermal Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Transdermal Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Transdermal Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Transdermal Preparation Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Transdermal Preparation Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Preparations
  • Non Injectable Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novastage Pharmaceuticals (Shenzhen)
  • Novartis
  • Luye Pharma Group
  • Hunan Jiudian Pharmaceutical
  • Harbin Hexinotai Pharmaceutical Technology
  • GSK
  • Demo Technology
  • Guangzhou Continent Biomedical Technology
  • Beijing Tide Pharmaceutical
  • Viatris
  • Transdermal Corporation
  • Nitto
  • MEDRx
  • Medpharm
  • ERCO Pharma
  • 4P Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Preparation Sales Value (2021-2032)
  4. 1.2.2 Global Transdermal Preparation Sales Volume (2021-2032)
  5. 1.2.3 Global Transdermal Preparation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transdermal Preparation Market Dynamics
  1. 2.1 Transdermal Preparation Industry Trends
  2. 2.2 Transdermal Preparation Industry Drivers
  3. 2.3 Transdermal Preparation Industry Opportunities and Challenges
  4. 2.4 Transdermal Preparation Industry Restraints
3 Transdermal Preparation Market by Company
  1. 3.1 Global Transdermal Preparation Company Revenue Ranking in 2025
  2. 3.2 Global Transdermal Preparation Revenue by Company (2021-2026)
  3. 3.3 Global Transdermal Preparation Sales Volume by Company (2021-2026)
  4. 3.4 Global Transdermal Preparation Average Price by Company (2021-2026)
  5. 3.5 Global Transdermal Preparation Company Ranking (2024-2026)
  6. 3.6 Global Transdermal Preparation Company Manufacturing Base and Headquarters
  7. 3.7 Global Transdermal Preparation Company Product Type and Application
  8. 3.8 Global Transdermal Preparation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transdermal Preparation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transdermal Preparation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transdermal Preparation Market by Type
  1. 4.1 Transdermal Preparation Type Introduction
  2. 4.1.1 Injectable Preparations
  3. 4.1.2 Non Injectable Preparations
  4. 4.2 Global Transdermal Preparation Sales Volume by Type
  5. 4.2.1 Global Transdermal Preparation Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Transdermal Preparation Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Transdermal Preparation Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Transdermal Preparation Sales Value by Type
  9. 4.3.1 Global Transdermal Preparation Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Transdermal Preparation Sales Value by Type (2021-2032)
  11. 4.3.3 Global Transdermal Preparation Sales Value Share by Type (2021-2032)
5 Transdermal Preparation Market by Application
  1. 5.1 Transdermal Preparation Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Transdermal Preparation Sales Volume by Application
  6. 5.2.1 Global Transdermal Preparation Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transdermal Preparation Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Transdermal Preparation Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Transdermal Preparation Sales Value by Application
  10. 5.3.1 Global Transdermal Preparation Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transdermal Preparation Sales Value by Application (2021-2032)
  12. 5.3.3 Global Transdermal Preparation Sales Value Share by Application (2021-2032)
6 Transdermal Preparation Regional Sales and Value Analysis
  1. 6.1 Global Transdermal Preparation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Preparation Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Preparation Sales by Region: 2021-2026
  4. 6.2.2 Global Transdermal Preparation Sales by Region (2027-2032)
  5. 6.3 Global Transdermal Preparation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transdermal Preparation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transdermal Preparation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transdermal Preparation Sales Value by Region (2027-2032)
  9. 6.5 Global Transdermal Preparation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transdermal Preparation Sales Value (2021-2032)
  12. 6.6.2 North America Transdermal Preparation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transdermal Preparation Sales Value (2021-2032)
  15. 6.7.2 Europe Transdermal Preparation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transdermal Preparation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transdermal Preparation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transdermal Preparation Sales Value (2021-2032)
  21. 6.9.2 South America Transdermal Preparation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transdermal Preparation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transdermal Preparation Sales Value Share by Country, 2025 VS 2032
7 Transdermal Preparation Country-level Sales and Value Analysis
  1. 7.1 Global Transdermal Preparation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transdermal Preparation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transdermal Preparation Sales by Country (2021-2032)
  4. 7.3.1 Global Transdermal Preparation Sales by Country (2021-2026)
  5. 7.3.2 Global Transdermal Preparation Sales by Country (2027-2032)
  6. 7.4 Global Transdermal Preparation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transdermal Preparation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transdermal Preparation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transdermal Preparation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transdermal Preparation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transdermal Preparation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transdermal Preparation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transdermal Preparation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transdermal Preparation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transdermal Preparation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transdermal Preparation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transdermal Preparation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transdermal Preparation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transdermal Preparation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transdermal Preparation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transdermal Preparation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transdermal Preparation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transdermal Preparation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transdermal Preparation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transdermal Preparation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transdermal Preparation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transdermal Preparation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transdermal Preparation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transdermal Preparation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transdermal Preparation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transdermal Preparation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transdermal Preparation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transdermal Preparation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transdermal Preparation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transdermal Preparation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transdermal Preparation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transdermal Preparation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transdermal Preparation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novastage Pharmaceuticals (Shenzhen)
  2. 8.1.1 Novastage Pharmaceuticals (Shenzhen) Company Information
  3. 8.1.2 Novastage Pharmaceuticals (Shenzhen) Business Overview
  4. 8.1.3 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novastage Pharmaceuticals (Shenzhen) Transdermal Preparation Product Portfolio
  6. 8.1.5 Novastage Pharmaceuticals (Shenzhen) Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Transdermal Preparation Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Luye Pharma Group
  14. 8.3.1 Luye Pharma Group Company Information
  15. 8.3.2 Luye Pharma Group Business Overview
  16. 8.3.3 Luye Pharma Group Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Luye Pharma Group Transdermal Preparation Product Portfolio
  18. 8.3.5 Luye Pharma Group Recent Developments
  19. 8.4 Hunan Jiudian Pharmaceutical
  20. 8.4.1 Hunan Jiudian Pharmaceutical Company Information
  21. 8.4.2 Hunan Jiudian Pharmaceutical Business Overview
  22. 8.4.3 Hunan Jiudian Pharmaceutical Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Jiudian Pharmaceutical Transdermal Preparation Product Portfolio
  24. 8.4.5 Hunan Jiudian Pharmaceutical Recent Developments
  25. 8.5 Harbin Hexinotai Pharmaceutical Technology
  26. 8.5.1 Harbin Hexinotai Pharmaceutical Technology Company Information
  27. 8.5.2 Harbin Hexinotai Pharmaceutical Technology Business Overview
  28. 8.5.3 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Hexinotai Pharmaceutical Technology Transdermal Preparation Product Portfolio
  30. 8.5.5 Harbin Hexinotai Pharmaceutical Technology Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Transdermal Preparation Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Demo Technology
  38. 8.7.1 Demo Technology Company Information
  39. 8.7.2 Demo Technology Business Overview
  40. 8.7.3 Demo Technology Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Demo Technology Transdermal Preparation Product Portfolio
  42. 8.7.5 Demo Technology Recent Developments
  43. 8.8 Guangzhou Continent Biomedical Technology
  44. 8.8.1 Guangzhou Continent Biomedical Technology Company Information
  45. 8.8.2 Guangzhou Continent Biomedical Technology Business Overview
  46. 8.8.3 Guangzhou Continent Biomedical Technology Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou Continent Biomedical Technology Transdermal Preparation Product Portfolio
  48. 8.8.5 Guangzhou Continent Biomedical Technology Recent Developments
  49. 8.9 Beijing Tide Pharmaceutical
  50. 8.9.1 Beijing Tide Pharmaceutical Company Information
  51. 8.9.2 Beijing Tide Pharmaceutical Business Overview
  52. 8.9.3 Beijing Tide Pharmaceutical Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Tide Pharmaceutical Transdermal Preparation Product Portfolio
  54. 8.9.5 Beijing Tide Pharmaceutical Recent Developments
  55. 8.10 Viatris
  56. 8.10.1 Viatris Company Information
  57. 8.10.2 Viatris Business Overview
  58. 8.10.3 Viatris Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Viatris Transdermal Preparation Product Portfolio
  60. 8.10.5 Viatris Recent Developments
  61. 8.11 Transdermal Corporation
  62. 8.11.1 Transdermal Corporation Company Information
  63. 8.11.2 Transdermal Corporation Business Overview
  64. 8.11.3 Transdermal Corporation Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Transdermal Corporation Transdermal Preparation Product Portfolio
  66. 8.11.5 Transdermal Corporation Recent Developments
  67. 8.12 Nitto
  68. 8.12.1 Nitto Company Information
  69. 8.12.2 Nitto Business Overview
  70. 8.12.3 Nitto Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Nitto Transdermal Preparation Product Portfolio
  72. 8.12.5 Nitto Recent Developments
  73. 8.13 MEDRx
  74. 8.13.1 MEDRx Company Information
  75. 8.13.2 MEDRx Business Overview
  76. 8.13.3 MEDRx Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 MEDRx Transdermal Preparation Product Portfolio
  78. 8.13.5 MEDRx Recent Developments
  79. 8.14 Medpharm
  80. 8.14.1 Medpharm Company Information
  81. 8.14.2 Medpharm Business Overview
  82. 8.14.3 Medpharm Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Medpharm Transdermal Preparation Product Portfolio
  84. 8.14.5 Medpharm Recent Developments
  85. 8.15 ERCO Pharma
  86. 8.15.1 ERCO Pharma Company Information
  87. 8.15.2 ERCO Pharma Business Overview
  88. 8.15.3 ERCO Pharma Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ERCO Pharma Transdermal Preparation Product Portfolio
  90. 8.15.5 ERCO Pharma Recent Developments
  91. 8.16 4P Therapeutics
  92. 8.16.1 4P Therapeutics Company Information
  93. 8.16.2 4P Therapeutics Business Overview
  94. 8.16.3 4P Therapeutics Transdermal Preparation Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 4P Therapeutics Transdermal Preparation Product Portfolio
  96. 8.16.5 4P Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Preparation Value Chain Analysis
  2. 9.1.1 Transdermal Preparation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Preparation Sales Mode & Process
  6. 9.2 Transdermal Preparation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Preparation Distributors
  9. 9.2.3 Transdermal Preparation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst